Odulimomab is a recombinant monoclonal antibody against CD11a. Odulimomab is a research drug used to prevent transplant rejection and treat various immune diseases. It is a mouse monoclonal antibody directed against the ? chain of the lymphocyte function-related antigen 1, a protein related to immune function.
There are no reviews yet.
Your email address will not be published. Required fields are marked *
In which application did you use the antibody? *
Did it work in your application? *
Your review *
Save my name, email, and website in this browser for the next time I comment.
Got a question or need a quote? Message us and we’ll get back to you 48 hours or less.
Lab / Company